Abstract
Advanced practitioners are ideal advocates for their patients with polycythemia vera who have had a thrombotic event to ensure that secondary prevention measures are in place, including the implementation of close monitoring and tailoring therapy to meet individual needs. Being equipped with the medical knowledge to identify patients who are displaying signs and symptoms of resistance or intolerance is key to minimizing disease- or therapy-related complications and ultimately provide personalized therapy for each patient.
